In:
Cancer, Wiley, Vol. 129, No. 17 ( 2023-09), p. 2741-2753
Abstract:
Older breast cancer survivors were biologically older than matched noncancer controls across multiple epigenetic aging measures at 24 months or more after enrollment (which was presystemic therapy for survivors). Older breast cancer survivors who had received chemotherapy showed the greatest epigenetic aging, and among this group, an older epigenetic age was associated with worse self‐reported cognition relative to controls.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v129.17
Language:
English
Publisher:
Wiley
Publication Date:
2023
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Permalink